admin

Not infrequently, Wall Street focuses excessively on relatively inconsequential details and ignores the “big picture.” When that happens, great long-term buying opportunities are frequently created. I think that phenomenon is playing out now with clean-energy stocks in general and Stem (NYSE:STEM) stock in particular. Source: Lightboxx/ShutterStock.com Stem has developed software, powered by artificial intelligence, that
0 Comments
Theoretically, we really should have seen a renaissance in value stocks during the impact of the novel coronavirus pandemic. With an unprecedented crisis rippling throughout the international community, the global equity markets initially tumbled on the mass spread of the disease. If anyone wanted to go contrarian, they should have done so on the companies
0 Comments
The pandemic created a shift from storefront to e-commerce, which is a trend that bodes well for fintech stocks. With global saving rates topping $5.4 trillion, we are likely to see an increase in consumer spending as we approach the new normal. With the digital payments expected to be the norm in the future, all
0 Comments
If you’re a believer in the growth of electric vehicles (EVs), Chargepoint (NYSE:CHPT) remains an attractive opportunity. And even though CHPT stock is slowly beginning to bounce off its springtime lows, there is plenty of upside remaining. Source: YuniqueB / Shutterstock.com As you may recall, Chargepoint is a special purpose acquisition company (SPAC) stock that
0 Comments
To achieve dividend kings status, a company has to provide its shareholders a dividend increase for at least 50 consecutive years. This is no mean feat, but consumer goods companies may have an advantage. Source: iQoncept/shutterstock.com Companies in the consumer staples sector sell everyday items, such as toothpaste, snacks, beverages and laundry detergent, that consumers
0 Comments
News of game-changing drugs, treatments and vaccines may dominate the headlines when it comes to pharmaceutical stocks. But, taking a gamble with high-risk, high-possible return biotech stocks isn’t the only way to approach this sector. There are less risky opportunities in this space. Sure, they may not generate the triple-digit percentage gains we’ve seen in
0 Comments
Driving the narrative for emerging markets is the fundamental reason why people invest: Find a great deal in the hopes that it will generate significant profits later. Naturally, those that love the concept of banking on emerging markets have gravitated toward companies like Jumia Technologies (NYSE:JMIA). As an e-commerce firm targeting several African countries, much
0 Comments
I continue to believe that FuboTV (NYSE:FUBO), with anything like its current content and price points, will never appeal to the vast majority of Americans. Meanwhile, I think that the platform’s appeal to sports bettors is greatly overblown. Given these points, I remain convinced that, despite its recent pullback, FUBO stock remains vastly overvalued. Source:
0 Comments